TC
MGNX icon

TFS Capital’s MacroGenics MGNX Stock Holding History

TFS Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-25,711
Closed -$478K – 706
2017
Q1 		$478K Sell
25,711
-49,090
-66% -$947K 0.16% 218
2016
Q4 		$1.53M Buy
+74,801
New +$1.88M 0.41% 39
2016
Q2 		– Sell
-86,649
Closed -$1.63M – 1099
2016
Q1 		$1.63M Sell
86,649
-28,686
-25% -$546K 0.23% 113
2015
Q4 		$3.57M Buy
115,335
+69,271
+150% +$2.1M 0.38% 57
2015
Q3 		$987K Sell
46,064
-132,598
-74% -$4.16M 0.1% 344
2015
Q2 		$6.78M Buy
178,662
+140,573
+369% +$4.62M 0.66% 4
2015
Q1 		$1.2M Sell
38,089
-42,367
-53% -$1.44M 0.12% 284
2014
Q4 		$2.82M Sell
80,456
-18,530
-19% -$462K 0.27% 102
2014
Q3 		$2.07M Buy
98,986
+78,379
+380% +$1.62M 0.18% 173
2014
Q2 		$448K Buy
20,607
+8,752
+74% +$184K 0.04% 686
2014
Q1 		$330K Buy
+11,855
New +$419K 0.02% 964

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital's MGNX Position: Q2 2017 in Review

TFS Capital sold out of MacroGenics (MGNX) in Q2 2017, closing a stake of 25,711 shares — an estimated $478K sold.

TFS Capital first reported a position in MGNX in Q1 2014 and held it in 11 quarters. The position peaked at $6.78M in Q2 2015. 113 funds tracked by Wall St. Rank hold MGNX as of Q2 2017.

  • TFS Capital reported no remaining MacroGenics position as of Q2 2017 after selling out during the quarter.
  • TFS Capital sold 25,711 MacroGenics shares in Q2 2017, an estimated $478K.
  • TFS Capital first reported a position in MacroGenics in Q1 2014 and held it in 11 quarters.
  • TFS Capital's MacroGenics position peaked at $6.78M in Q2 2015.
  • 113 funds tracked by Wall St. Rank held MacroGenics as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.